Skip to content
MedsAcross

Brand family

Temodar

Temozolomide · Merck Sharp & Dohme
United States
Presentations
7
Markets
1

Temodar is a brand of Temozolomide marketed by Merck Sharp & Dohme, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Temozolomide
Brand owner
Merck Sharp & Dohme
Registered in
United States
Strengths and forms
100 mg capsule, 140 mg capsule, 180 mg capsule, 20 mg capsule, 250 mg capsule, 5 mg capsule, 2.5 mg/mL powder for injection

All presentations

MedicineManufacturerRegisterAvailability
Temodar 100 mg capsuleOral Cold chainMerck Sharp & DohmeUS FDAAvailable on request
Temodar 140 mg capsuleOral Cold chainMerck Sharp & DohmeUS FDAAvailable on request
Temodar 180 mg capsuleOral Cold chainMerck Sharp & DohmeUS FDAAvailable on request
Temodar 20 mg capsuleOral Cold chainMerck Sharp & DohmeUS FDAAvailable on request
Temodar 250 mg capsuleOral Cold chainMerck Sharp & DohmeUS FDAAvailable on request
Temodar 5 mg capsuleOral Cold chainMerck Sharp & DohmeUS FDAAvailable on request
Temodar 2.5 mg/mL powder for injectionIntravenous Cold chainMerck Sharp & DohmeUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Temodar

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.